148 related articles for article (PubMed ID: 30837765)
1. Effects of Honey on Postprandial Hyperlipidemia and Oxidative Stress in Wistar Rats: Role of HMG-CoA Reductase Inhibition and Antioxidant Effect.
Erejuwa OO; Akpan JL; Uwaezuoke NJI; Nwobodo NN; Ezeokpo BC; Erhiano E; Araromi EJ; Ude UN; AbdulWahab M; Sulaiman SA
Niger J Physiol Sci; 2018 Dec; 33(2):129-138. PubMed ID: 30837765
[TBL] [Abstract][Full Text] [Related]
2. Hypolipidemic effect of β-caryophyllene to treat hyperlipidemic rats.
Baldissera MD; Souza CF; Grando TH; Doleski PH; Boligon AA; Stefani LM; Monteiro SG
Naunyn Schmiedebergs Arch Pharmacol; 2017 Feb; 390(2):215-223. PubMed ID: 27913825
[TBL] [Abstract][Full Text] [Related]
3. Bioactivity guided fractionation and hypolipidemic property of a novel HMG-CoA reductase inhibitor from Ficus virens Ait.
Iqbal D; Khan MS; Khan MS; Ahmad S; Hussain MS; Ali M
Lipids Health Dis; 2015 Mar; 14():15. PubMed ID: 25884722
[TBL] [Abstract][Full Text] [Related]
4. Hypocholesterolemic activity of cornelian cherry (Cornus mas L.) fruits.
Hosseinpour F; Shomali T; Rafieian-Kopaei M
J Complement Integr Med; 2017 Jun; 14(4):. PubMed ID: 28731315
[TBL] [Abstract][Full Text] [Related]
5. Cholesterol-lowering effects and potential mechanisms of different polar extracts from Cyclocarya paliurus leave in hyperlipidemic mice.
Jiang C; Wang Q; Wei Y; Yao N; Wu Z; Ma Y; Lin Z; Zhao M; Che C; Yao X; Zhang J; Yin Z
J Ethnopharmacol; 2015 Dec; 176():17-26. PubMed ID: 26477373
[TBL] [Abstract][Full Text] [Related]
6. Potential downregulation of HMG-CoA reductase after prolonged administration of P-407 in C57BL/6 mice.
Johnston TP; Baker JC; Jamal AS; Hall D; Emeson EE; Palmer WK
J Cardiovasc Pharmacol; 1999 Dec; 34(6):831-42. PubMed ID: 10598127
[TBL] [Abstract][Full Text] [Related]
7. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
8. Hypolipidemic and antioxidant activity of ethanolic extract of Symplocos racemosa Roxb. in hyperlipidemic rats: an evidence of participation of oxidative stress in hyperlipidemia.
Durkar AM; Patil RR; Naik SR
Indian J Exp Biol; 2014 Jan; 52(1):36-45. PubMed ID: 24617014
[TBL] [Abstract][Full Text] [Related]
9. Statins: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors demonstrate anti-atherosclerotic character due to their antioxidant capacity.
Puttananjaiah MK; Dhale MA; Gaonkar V; Keni S
Appl Biochem Biotechnol; 2011 Jan; 163(2):215-22. PubMed ID: 20640529
[TBL] [Abstract][Full Text] [Related]
10. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
[TBL] [Abstract][Full Text] [Related]
11. The Changes in Endogenous Metabolites in Hyperlipidemic Rats Treated with Herbal Mixture Containing Lemon, Apple Cider, Garlic, Ginger, and Honey.
Abu Bakar Sajak A; Azlan A; Abas F; Hamzah H
Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684574
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of antihyperlipidemic potency of a polyherbomineral formulation (AF-LIP) in experimental animal models.
Ashok P; Singh D; Poulose DN; Suresh B
Pak J Biol Sci; 2014 Feb; 17(3):346-55. PubMed ID: 24897788
[TBL] [Abstract][Full Text] [Related]
14. HMG-CoA reductase inhibition reverses LCAT and LDL receptor deficiencies and improves HDL in rats with chronic renal failure.
Liang K; Kim CH; Vaziri ND
Am J Physiol Renal Physiol; 2005 Mar; 288(3):F539-44. PubMed ID: 15507547
[TBL] [Abstract][Full Text] [Related]
15. Antidiabetic and antihyperlipidemic activity of asiatic acid in diabetic rats, role of HMG CoA: in vivo and in silico approaches.
Ramachandran V; Saravanan R; Senthilraja P
Phytomedicine; 2014 Feb; 21(3):225-32. PubMed ID: 24075211
[TBL] [Abstract][Full Text] [Related]
16. Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase.
Kim YS; Jung EA; Shin JE; Chang JC; Yang HK; Kim NJ; Cho KH; Bae HS; Moon SK; Kim DH
Biol Pharm Bull; 2002 Nov; 25(11):1442-5. PubMed ID: 12419956
[TBL] [Abstract][Full Text] [Related]
17. Investigation of HMG-CoA reductase inhibitory and antioxidant effects of various hydroxycoumarin derivatives.
Ozalp L; Danış Ö; Yuce-Dursun B; Demir S; Gündüz C; Ogan A
Arch Pharm (Weinheim); 2020 Oct; 353(10):e1900378. PubMed ID: 32648617
[TBL] [Abstract][Full Text] [Related]
18. Influence of high cholesterol diet and pravastatin sodium on the initiation of liver regeneration in rats after partial hepatectomy.
Zivna H; Zivny P; Palicka V; Simakova E
Nutrition; 2002 Jan; 18(1):51-5. PubMed ID: 11827765
[TBL] [Abstract][Full Text] [Related]
19. Preservation of endothelial function by the HMG-CoA reductase inhibitor fluvastatin through its lipid-lowering independent antioxidant properties in atherosclerotic rabbits.
Mitani H; Egashira K; Ohashi N; Yoshikawa M; Niwa S; Nonomura K; Nakashima A; Kimura M
Pharmacology; 2003 Jul; 68(3):121-30. PubMed ID: 12784083
[TBL] [Abstract][Full Text] [Related]
20. Effect of cyclosporine on HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LDL receptor, HDL receptor, VLDL receptor, and lipoprotein lipase expressions.
Vaziri ND; Liang K; Azad H
J Pharmacol Exp Ther; 2000 Aug; 294(2):778-83. PubMed ID: 10900260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
